Reviva Pharmaceuticals Holdings, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | — | — | $0 |
| FY2019 | $2.2M | $65.6M | $313.0K |
| FY2020 | $3.3M | $61.0M | $69.3K |
| FY2021 | $2.7M | $31.4M | $29.7M |
| FY2022 | $6.5M | $18.9M | $18.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | — | — | $0 |
| FY2019 | $2.2M | $65.6M | $313.0K |
| FY2020 | $3.3M | $61.0M | $69.3K |
| FY2021 | $2.7M | $31.4M | $29.7M |
| FY2022 | $6.5M | $18.9M | $18.5M |